Key result
IVUS-guided PCI optimization provides consistent target vessel failure reduction across NSTE-ACS and CCS.
Why the study?
Does IVUS-guided PCI optimization yield similar physiological and clinical benefits in patients with suboptimal post-PCI FFR presenting with NSTE-ACS versus CCS?
RCT (n=291)
Does IVUS-guided PCI optimization yield similar physiological and clinical benefits in patients with suboptimal post-PCI FFR presenting with NSTE-ACS versus CCS?
p-value: p=0.36
IVUS-guided optimization of suboptimal post-PCI FFR provides comparable physiological improvements and clinical outcomes regardless of whether patients present with NSTE-ACS or CCS.
BACKGROUND: Intravascular ultrasound (IVUS)-guided optimization of suboptimal fractional flow reserve (FFR) following percutaneous coronary intervention (PCI) results in a significant increase in both post-PCI FFR and minimal lumen and stent areas (MLA and MSA, respectively). However, the impact of clinical presentation with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) versus chronic coronary syndrome (CCS) on the efficacy of PCI optimization remains unknown. METHODS: This was a prespecified subgroup analysis of the FFR REACT trial comparing IVUS-guided PCI optimization versus no further treatment in 291 patients with a post-PCI FFR < 0.90. Post-PCI physiology and pre optimization IVUS findings were compared between patients presenting with NSTE-ACS versus CCS, as well as optimization strategy, final FFR and IVUS findings. RESULTS: , p = 0.61), respectively. The clinical impact of IVUS-guided optimization on 2-year target vessel failure showed no signs of heterogeneity based on clinical presentation (interaction p = 0.36). CONCLUSIONS: In patients undergoing FFR-directed IVUS-guided optimization, post-PCI FFR, pre optimization IVUS findings and optimization strategy did not differ significantly between patients presenting with either NSTE-ACS or CCS, with comparable improvements in FFR, MLA and MSA.
No takes yet. Share an insight, caveat, or question.
Groenland et al. (2024) conducted an RCT in Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) versus chronic coronary syndrome (CCS) (n=291). IVUS-guided PCI optimization vs. No further treatment was evaluated on 2-year target vessel failure (p=0.36). The clinical impact of IVUS-guided PCI optimization on 2-year target vessel failure showed no signs of heterogeneity between patients presenting with NSTE-ACS versus CCS (interaction p = 0.36).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: